Latest Commercial Strategy News

AnteoTech Ltd reports a strong FY2025 with doubled sales revenue, strategic partnerships, and key product milestones in battery materials and life sciences diagnostics.

ARN Media reported a 7% revenue decline in the first half of FY25 amid audience challenges and a sluggish post-election market, yet digital audio revenue surged 21%. A $40 million transformational cost-out program and leadership overhaul set the stage for a strategic reset and growth in the second half.

Hazer Group has reported a remarkable FY25 performance with revenues more than doubling and losses slashed by 60%, underpinned by a strategic partnership with KBR and early commercial revenues.

An independent in vivo study from the University of South Florida reveals ArtemiC™ significantly boosts survival and reduces inflammation in a severe viral model, reinforcing its promise as a novel immunomodulatory therapy.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.

Lindian Resources has raised A$91.5 million through a strong institutional placement, enabling the final investment decision for the Kangankunde Rare Earths Project’s Stage 1 development with production targeted for late 2026.

EMVision Medical Devices has been awarded a $3 million non-dilutive government grant to conduct a pioneering clinical study using its telehealth-enabled emu™ brain scanner in regional South Australia, aiming to transform stroke diagnosis and treatment.

EBR Systems has secured FDA approval for its pioneering leadless WiSE CRT System and obtained key Medicare reimbursement endorsements, setting the stage for its commercial rollout. The company also completed a significant capital raise to support its market expansion.

Firebird Metals has received a significant Expression of Interest from Taza Metal Technologies to purchase up to five of its energy-efficient kilns, potentially generating over US$10 million in revenue. This marks a key step in Firebird’s international commercial expansion and highlights its leadership in sustainable manganese processing technology.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.

Alexium International Group faced a tough FY25 with declining sales amid a soft US mattress market but is poised for growth in FY26 thanks to technological advances and strategic funding support.